Related Experiment Video
Updated: Jun 3, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
Published on: December 8, 2023
Recombinant Mycobacterium smegmatis vaccine candidates
Ildikó Faludi1, Agnes Míra Szabó, Katalin Burián
1University of Szeged, Department of Medical Microbiology and Immunobiology, Szeged, Hungary. faludi.ildiko@gmail.com
Abstract:
Mycobacterium smegmatis is a species of rapidly growing saprophytes with a number of properties that make it an effective vaccine vector. Recombinant M. smegmatis expressing protective antigens of different pathogens and molecules modulating the immune responses offers some potential for reduction of the burden of tuberculosis, HIV and hepatitis B infections. This paper discusses the molecular methods used to generate recombinant M. smegmatis and the results obtained with some of these recombinants.

